510(k) device
Vestibular Analysis Apparatus
Capacity Sports, LLC · Apparatus, Vestibular Analysis (LXV, Unclassified) · First FDA decision Sep 20, 2012, newest Sep 20, 2012
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
215
Naming "Vestibular"
MAUDE reports
0
Brand "Vestibular", since 2015
PubMed studies
51,651
Mentioning "Vestibular"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Vestibular Analysis Apparatus
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K121590 · Decided Sep 20, 2012 · 112 days after receipt
Device type: Apparatus, Vestibular Analysis (LXV) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Vestibular Function TestingLocal determinationIn effectL34537Palmetto GBAUpdated Sep 3, 2021
- Vestibular and Audiologic Function StudiesLocal determinationIn effectL35007Novitas Solutions, Inc.Updated Oct 11, 2019
- Vestibular Function TestsLocal determinationIn effectL33966First Coast Service Options, Inc.Updated Oct 2, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "Vestibular", any status and sponsor, newest update first.
- Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD)Withdrawn
Neurovalens Ltd.Not on our public-company list
NCT06470035 · 0 participants · Start Jan 6, 2027 · Primary completion Apr 2027
Device: Active VeNS Device; Sham VeNS Device · For: Major Depressive Disorder \(MDD; Depressive Disorder, Major
Sites: San Diego, California; Belfast, United Kingdom
- Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain InjuryRecruiting
University of MiamiAcademic, hospital or other
NCT07356167 · 75 participants (planned) · Start Dec 15, 2025 · Primary completion Dec 31, 2026
Device: Passive neurosensory reintegration training (PNRT) · For: Mild Traumatic Brain Injury
Sites: Miami, Florida
- The Effect of Pinhole Glasses on Vestibular Electrical StimulationPivotal-lookingCompleted
Istanbul UniversityAcademic, hospital or other
NCT05516017 · 100 participants · Start Oct 15, 2022 · Primary completion Jul 15, 2023
Device: Vestibular Electrical Stimulator and Pinhole Glasses; Vestibular Electrical Stimulator · For: Vertigo, Peripheral
Sites: Istanbul, Turkey (Türkiye)
212 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Vestibular", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LXV
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Vestibular"[tiab]. The summary above synthesizes these.
- Vestibular migraine: Diagnostic criteria1.
Lempert T, Olesen J, Furman J, et al. · J Vestib Res · 2022Research Support, Non-U.S. Gov't
- Advances in Vestibular Rehabilitation.
Sulway S, Whitney SL · Adv Otorhinolaryngol · 2019Review
- [Vestibular migraine].
Illarionova EM, Gribova NP · Zh Nevrol Psikhiatr Im S S Korsakova · 2022
- Vestibular Disorders.
Pokhrel PK, Hall R, Pendergrass M, et al. · Prim Care · 2025Review
- Vestibular disease in dogs and cats.
Rossmeisl JH · Vet Clin North Am Small Anim Pract · 2010Review
- Acute Vestibular Syndrome.
Steenerson KK · Continuum (Minneap Minn) · 2021Review
- Vestibular Testing.
Hain TC, Cherchi M · Continuum (Minneap Minn) · 2021Review
- Vestibular migraine: diagnostic criteria.
Lempert T, Olesen J, Furman J, et al. · J Vestib Res · 2012Research Support, Non-U.S. Gov't
- [Vestibular vertigo].
Antonenko LM, Parfenov VA · Zh Nevrol Psikhiatr Im S S Korsakova · 2020
- Vestibular migraine.
Furman JM, Balaban CD · Ann N Y Acad Sci · 2015Review
- [Vestibular neuritis].
Hansen S, Cayé-Thomasen P, Boesen J, et al. · Ugeskr Laeger · 2008English Abstract, Review
Other devices of this type
Also filed under product code LXV.
- GyroStimUltrathera Technologies, Inc. · 510(k) 2022
- OrionInteracoustics A/S · 510(k) 2020
- TrvInteracoustics A/S · 510(k) 2020
- ClearEdge Balance SystemQuadrant Biosciences · 510(k) 2019
- EQ BalanceUpright Science, Inc. · 510(k) 2019
- K-D BalanceKing-Devick Technologies, Inc. · 510(k) 2018
- Nydiag 200Interacoustics A/S · 510(k) 2010
- Vertigone Bppv GoggleVertigone, Inc. · 510(k) 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.